Business

Add as a preferred source on Google

Edgewell Forecasts 1% to 3% Organic Sales Growth for Fiscal 2027

Organic sales rose 0.3% in fiscal 2026, while continuing operations posted a $2.2 million loss. Edgewell expects about $55 million in pretax charges next year.

Updated 2 min read
A shopper compares shaving products in a pharmacy aisle in Shelton, Connecticut. (AI-generated image / EconoTimes)
A shopper compares shaving products in a pharmacy aisle in Shelton, Connecticut. (AI-generated image / EconoTimes)

Edgewell Personal Care expects organic sales to rise 1% to 3% in fiscal 2027 after a 0.3% increase this year, while forecasting adjusted earnings per share of $1.85 to $2.15.

For the year ended Sept. 30, 2026, net sales reached $1.997 billion, up 1.8%. Fourth-quarter sales were $484.1 million, a 3% increase, while organic sales grew 3.1%. Organic sales rose 3.3% in North America and 3% in international markets.

Adjusted earnings per share for the full year climbed to $1.93 from $1.81 in fiscal 2025. On a GAAP basis, continuing operations posted a $2.2 million loss, compared with $44.3 million in income a year earlier. The company’s total net loss was $51.7 million, including a $49.5 million loss from Feminine Care, which Edgewell classifies as a discontinued operation.

In the fourth quarter, adjusted earnings per share increased to $0.78 from $0.52 a year earlier. GAAP earnings from continuing operations were $10.7 million, or $0.23 per diluted share, compared with $12.1 million, or $0.26 per share, in the prior-year quarter.

Restructuring and related costs totaled $101.8 million in fiscal 2026. Edgewell tied $80 million to consolidating Mexico facilities and Wet Shave operations, and $21.8 million to global transformation actions. For fiscal 2027, it expects about $55 million in pretax charges, including further Wet Shave consolidation.

The company’s fiscal 2027 outlook also includes reported sales growth of 0.4% to 2.4%, with foreign currency expected to reduce growth by 0.6 percentage point. Edgewell projected adjusted operating margin expansion of about 70 basis points, adjusted EBITDA of $250 million to $270 million and GAAP earnings per share of $0.90 to $1.20.

Rod Little, Edgewell’s president and CEO, said the company believes its broader operating-model transformation is creating greater capacity to invest despite persistent cost and competitive pressures. The release’s financial statements are labeled unaudited. Edgewell declared a dividend of $0.15 per share on Nov. 12, payable Jan. 7, 2027, to shareholders of record Dec. 3, 2026.

Related articles

View all